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RESEARCH ARTICLE
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Abstract
Left ventricular non-compaction (LVNC) is a rare cardiomyopathy associated with a hyper-
trabeculated phenotype and a large spectrum of symptoms. It is still unclear whether LVNC
results from a defect of ventricular trabeculae development and the mechanistic basis that
underlies the varying severity of this pathology is unknown. To investigate these issues, we
inactivated the cardiac transcription factor Nkx2-5 in trabecular myocardium at different
stages of trabecular morphogenesis using an inducible Cx40-creERT2 allele. Conditional
deletion of Nkx2-5 at embryonic stages, during trabecular formation, provokes a severe
hypertrabeculated phenotype associated with subendocardial fibrosis and Purkinje fiber
hypoplasia. A milder phenotype was observed after Nkx2-5 deletion at fetal stages, during
trabecular compaction. A longitudinal study of cardiac function in adult Nkx2-5 conditional
mutant mice demonstrates that excessive trabeculation is associated with complex ventricu-
lar conduction defects, progressively leading to strain defects, and, in 50% of mutant mice,
to heart failure. Progressive impaired cardiac function correlates with conduction and strain
defects independently of the degree of hypertrabeculation. Transcriptomic analysis of
molecular pathways reflects myocardial remodeling with a larger number of differentially
expressed genes in the severe versus mild phenotype and identifies Six1 as being upregu-
lated in hypertrabeculated hearts. Our results provide insights into the etiology of LVNC and
link its pathogenicity with compromised trabecular development including compaction
defects and ventricular conduction system hypoplasia.
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During fetal heart morphogenesis, formation of the mature ventricular wall requires coor-
dinated compaction of the inner trabecular layer and growth of the outer layer of myocar-
dium. Arrested trabecular development has been implicated in the pathogenesis of
hypertrabeculation associated with ventricular non-compaction cardiomyopathy. How-
ever much uncertainty still exists among clinicians concerning the physiopathology of
ventricular non-compaction cardiomyopathy, including its clinical characteristics, prog-
nosis, classification and even the definition of hypertrabeculation. In particular, distin-
guishing between pathological and non-pathological subtypes of non-compaction is
currently a major issue. Here we show that deletion of the gene encoding the transcription
factor Nkx2-5 at critical steps during trabecular development recapitulates pathological
features of hypertrabeculation, providing the first model of ventricular non-compaction
cardiomyopathy in adult mice. We demonstrate that excessive trabeculation due to failure
of trabecular compaction during fetal development is associated with Purkinje fiber hypo-
plasia and subendocardial fibrosis. Longitudinal functional studies reveal that these mice
present all the clinical signs of symptomatic left ventricular non-compaction cardiomyop-
athy, including conduction defects, strain defects and progressive heart failure. Our
results, including transcriptomic analysis, suggest that pathological features of non-com-
paction are primarily developmental defects. This study clarifies the origin of the patho-
logical outcomes associated with LVNC and may provide helpful information for
clinicians concerning the etiology of this rare cardiomyopathy.
Introduction
Left ventricular non-compaction (LVNC) or hypertrabeculation is a cardiac anomaly charac-
terized by a thickened sub-endocardial layer of ventricular myocardium with prominent trabe-
culations and deep recesses that communicate with the left ventricular (LV) cavity [1]. The
recent classification of LVNC as the third most common form of cardiomyopathy is still
debated because of the strong variability in pathophysiology, clinical symptoms and genetic
associations [2, 3]. LVNC has been described as a genetic disorder caused by mutations in
genes encoding sarcomere, cytoskeletal, nuclear membrane, ionic channels and chaperone
proteins [4, 5]. Most importantly, LVNC can be asymptomatic but complications including
heart failure (HF), thromboembolism and malignant arrhythmia are often observed [6]. The
relatively recent interest of clinicians in LVNC comes from the increasing number of patients
presenting signs of hypertrabeculation in the last 25 years, due to significant improvements in
cardiac imaging using echocardiography or Magnetic Resonance Imaging (MRI). However,
the phenotypic variability of this anomaly raises major problems for clinicians concerning its
pathological nature. In particular, the wide spectrum of clinical signs makes prognosis of
LVNC difficult. To understand the etiology of this non-compaction the generation of adult
mouse models is essential.
The anatomic resemblance between human cases of LVNC and embryonic hearts have sug-
gested that this anomaly results from an arrest of myocardial compaction during fetal develop-
ment [7]. This hypothesis is now well established in several mouse models [8–11]; however, it
does not explain the occurrence of different LVNC subtypes. The presence of ventricular tra-
beculae is assumed to be critical for oxygenation and conduction in the developing heart [12].
Trabeculation is initiated by the formation of endocardial outpockets in which trabecular
myocardium develops by proliferation of cardiomyocytes forming a two-layer myocardium
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with a compact and a trabecular zone. In contrast to fishes and reptiles, mammalian trabeculae
are not maintained in the adult heart, their reduction occurs by a process of compaction that
initiates during fetal stages and ends after birth [13]. This is thought to arise by coalescence of
trabeculae, which are progressively incorporated to the compact myocardium as well as form-
ing papillary muscles [14]; however, the mechanisms underlying compaction of the ventricular
trabeculae remain unknown. Moreover, trabecular development is directly coupled with the
development of the ventricular conduction system. The function of the conduction system is
to generate and orchestrate the propagation of the electrical activity through the heart in order
to coordinate the sequential contraction of atria and ventricles [15]. The gap junction Con-
nexin40 (Cx40) characterized by high conductance properties is strongly expressed in ventric-
ular trabeculae and Cx40+ cardiomyocytes form preferential conduction pathways in the
embryonic heart [16].
The cardiac transcription factor Nkx2-5 is an important regulator of ventricular trabeculae
and conduction system development. Nkx2-5+/- haploinsufficient mice have an abnormal elec-
trocardiogram, with a prolonged QRS and progressive elongation of the PR interval [17, 18].
These mice display ventricular conduction defects that can be correlated with hypoplastic
development of the His-Purkinje system [19]. More recently, NKX2-5 mutations have been
identified in LVNC patients indicating a role of this transcription factor in compaction [8, 20].
Indeed, conditional inactivation of Nkx2-5 in the ventricular myocardium showed that this
deficiency provokes a hypertrabeculated phenotype resulting from defective myocardial prolif-
eration [10]. In order to investigate the impact of the loss of Nkx2-5 during trabecular develop-
ment, we have now conditionally inactivated this gene in the ventricular trabeculae in a
spatiotemporally controlled manner using an inducible Cx40-creERT2 mouse model [21]. This
study demonstrates that deletion of Nkx2-5 during trabecular development recapitulates in
adult mice pathological features associated with LVNC and represents a highly tractable model
to study the cellular and molecular mechanisms involved in the disease as well as the patholog-
ical evolution of LVNC.
Results
Spatiotemporal deletion of Nkx2-5 in the ventricular trabecular
myocardium
Our strategy to conditionally inactivate Nkx2-5 in the developing ventricular trabeculae is
summarized in Fig 1A. We crossed mice containing Floxed-Nkx2-5-Δneo alleles with Cx40-
creERT2 mice in which Cre recombinase is broadly expressed in embryonic trabecular myo-
cardium [21, 22]. Tamoxifen was injected into pregnant females at embryonic (E10.5-E11.5)
or fetal (E13.5-E14.5) stages to remove Nkx2-5 during the formation of ventricular trabeculae
(Nkx2-5ΔTrbE10) or during the step of trabecular compaction (Nkx2-5ΔTrbE14) respectively.
The efficiency of Nkx2-5 deletion was verified by immunofluorescence on sections from
control, Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutant hearts. Numerous Nkx2-5-negative cardio-
myocytes were observed in the apex, the papillary muscles and left ventricular free wall after
tamoxifen injection at embryonic or fetal stages (Fig 1B). We performed a genetic tracing anal-
ysis of Cx40-cre derived cells to evaluate the extent of cardiac tissue affected by Nkx2-5 dele-
tion. We crossed Cx40-cre mice with Rosa26-YFP reporter mice and observed the localization
of YFP-positive cells in adult hearts by immunofluorescence on sections after tamoxifen
induction at E10 or E14 (Fig 1C). YFP-positive cardiomyocytes were observed throughout the
left ventricle, including compact zone myocardium, after induction at E10 while YFP+ cells
are restricted to the inner half of the LV wall after induction at fetal stages, consistent with pre-
vious observations [16]. Almost no YFP staining was detected in the RV, in accordance with
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the low level of expression of Cx40 in this ventricle. These data are consistent with a contribu-
tion of ventricular trabeculae at embryonic and fetal stages to the morphogenesis of the papil-
lary muscles and ventricular free wall with limited contributions to the interventricular
septum. Quantification of Nkx2-5-positive subendocardial cardiomyocytes shows a significant
reduction in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutants after two consecutive tamoxifen injec-
tions at embryonic or fetal stages (Fig 1D). Consistent with the dynamic expression profile of
Cx40 and our genetic tracing results, Nkx2-5 is deleted in a large proportion of the ventricular
myocardium when tamoxifen was injected at embryonic stages, while deletion is restricted to
the subendocardial zone at fetal stages (Fig 1E). These data suggest that the participation of
Cx40-derived trabecular cells to the ventricular wall is reduced as trabecular compaction pro-
gresses during cardiac development.
Temporal deletion of Nkx2-5 induces hypertrabeculation accompanied by
deep endocardial recesses
Morphological analyses using high-resolution cine-MRI showed that the papillary muscles fail
to coalesce and are enlarged and separated into multiple strands in adult Nkx2-5ΔTrbE10 and
Nkx2-5ΔTrbE14 hearts (Figs 2A, S1A and S1B). In addition numerous trabeculations were
observed in the left ventricular cavities of Nkx2-5ΔTrbE10 and to a lesser extent Nkx2-5ΔTrbE14
hearts (Fig 2A). We confirmed these results by histological analysis on transverse sections of
adult hearts and showed that the compact zone of the myocardium is not affected, nor is the
right ventricle (Figs 2B and S1C). To identify ventricular trabeculations, we performed co-
immunofluorescence using antibodies labeling endothelial cells, Endoglin (Eng) and VEGFR2,
to distinguish Eng+/VEGFR2- endocardium from Englow/VEGFR2+ coronary vascular endo-
thelial cells [23]. Excessive trabeculations evidenced by extensive invaginations of the endocar-
dium (arrows in Fig 2C) are found in both Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 compared to
control hearts. Four-chamber views of these hearts reveal a distribution of these trabeculations
throughout the base-apex axis (Figs 2D and S1). To quantify these hypertrabeculated pheno-
types, we measured the length of the endocardium in sections through the cardiac apex and at
the mid-ventricular level. Endocardial length was greater in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14
compared to control hearts (Fig 2F). As the formation of coronary vasculature accompanies
postnatal ventricular compaction [24], we investigated coronary artery density by counting the
number of arteries identified by Cx40-RFP and SMA staining and observed no significant dif-
ferences in artery density between these mice (S1C Fig). However, we observed the presence of
endocardial cells defined by a strong expression of Endoglin (arrows) in the subendocardial
myocardium (Figs 2C and S1C). These endocardial cells are organized in islets, are negative
for VEGFR2 and are not associated with SMCs. Ex-vivo perfusion of the fluorescent lectin
WGA-Cy3 (Wheat Germ Agglutinin) into the left ventricle of control and Nkx2-5ΔTrbE10 hearts
demonstrated that endocardial islets are in direct communication with the endocardium, in
Fig 1. Gene targeting strategy and validation of conditional deletion of Nkx2-5 in ventricular trabeculae. (A) Schematic illustration of the
gene targeting strategy. Conditional Nkx2-5 inactivation (Nkx2-5-/-) was obtained by crossing mice containing an Nkx2-5 floxed allele with
tamoxifen-inducible Cx40-cre-ERT2 mice. Time course of tamoxifen injections and cardiac phenotyping analyses are represented on a time scale
and the corresponding Nkx2-5 mutant groups, i.e. ΔTrbE10 and ΔTrbE14 are indicated below the scale. (B) Nkx2-5 immunofluorescence on
transversal sections of adult hearts from Control (Ctrl) and Nkx2-5ΔTrbE10 (ΔTrbE10) and Nkx2-5ΔTrbE14 (ΔTrbE14) mutant mice. (C) Genetic
tracing of ventricular trabeculae in Cx40-creERT2::R26-YFPmice at P20 showing the distribution of YFP+ in the apex and mid ventricle after Cre
induction at E10 or E14. (D) Nkx2-5 deletion was quantified by counting the percentage of Nkx2-5-positive cardiomyocytes per frame at the
subendocardial surface of transverse sections of adult Control (CTL), Nkx2-5ΔTrbE10 (ΔTrbE10) and Nkx2-5ΔTrbE14 (ΔTrbE14) mutant mice.
n = 20–30 frames per heart; N = 3 mice per group; Mean±SEM; p<0.001 Nkx2-5ΔTrbE10 vs control, p<0.001 Nkx2-5ΔTrbE14 vs control (E)
Schematic representation of the Nkx2-5-deleted cardiac regions in the apex or in mid-ventricle after tamoxifen injection at embryonic stages
(ΔTrbE10) or fetal stages (ΔTrbE14). IVS: interventricular septum; pm: papillary muscle.
https://doi.org/10.1371/journal.pgen.1007502.g001
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Fig 2. Morphology of adult hypertrabeculation induced by conditional deletion of Nkx2-5 in cardiomyocytes during trabecular
development. (A) Short-axis cine images recorded by CMR at end-diastole show anatomical structures of LV of 3 months-old
control (CTL), Nkx2-5ΔTrbE10 (ΔTrbE10) and Nkx2-5ΔTrbE14 (ΔTrbE14) mutant mice. Stars indicate the papillary muscles, and
arrowheads indicate excessive trabeculations. RV: right ventricle; IVS: interventricular septum; LV: left ventricle. Scale bar = 1mm.
(B) Eosin staining on transversal sections of the mid-ventricle from control, Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 adult hearts. The dotted
lines delimit the boundary between trabecular and compact zones in LV. (C) Immunofluorescence with endoglin, SMA and VEGFR2
antibodies to delineate endocardium (Enghigh/VEGFR2-) and vascular endothelial cells (Englow/VEGFR2+) on transversal sections of
the mid-ventricle from control, Nkx2-5ΔTrbE10, and Nkx2-5ΔTrbE14 adult hearts. Scale bar = 500μm. On the right panel, high
Developmental origins of pathological ventricular non-compaction
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contrast to WGA-negative coronary vasculature (Fig 2D and 2E). These results strongly sug-
gest that endocardial islets correspond to deep endocardial invaginations due to defective tra-
becular compaction. Quantification revealed a significantly larger number of endocardial islets
in Nkx2-5ΔTrbE10 mutant hearts than in control or Nkx2-5ΔTrbE14 hearts (Fig 2G). Together,
these results suggest that excessive trabeculations detected in Nkx2-5 mutant hearts result from
defects in trabecular compaction or coalescence. Furthermore, deletion of Nkx2-5 in embry-
onic versus fetal trabeculae results in increased phenotypic severity.
Hypertrabeculation after conditional Nkx2-5 loss of function is
accompanied by conduction system hypoplasia and subendocardial fibrosis
We investigated ventricular conduction system (VCS) development after conditional Nkx2-5
inactivation, by whole-mount immunofluorescence using the VCS marker Contactin-2 (Cntn-
2) in opened LV preparations of adult control, Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE4 hearts [25]. In
control hearts, Cntn-2 is detected in the entire VCS including the atrioventricular bundle
(AVB), left bundle branch (LBB) and Purkinje fibers (PF) network (Fig 3A). In mutant hearts
after Nkx2-5 deletion at embryonic or fetal stages, the PF network is strongly reduced while
the LBB and AVB develop normally (Figs 3A and S2). We used the software “Angiotool” to
quantify the complexity of the PF network [26]. In a branched structure, such as a vascular tree
or the PF network, this image analysis software calculates the number of branching events as
well as the length and density of vessels/fibers. Using Angiotool we observed a marked reduc-
tion of PF density and branching in Nkx2-5 mutant compared to control hearts (Fig 3B and
3C). However, while the PF network appears less affected in Nkx2-5ΔTrbE14 compared to Nkx2-
5ΔTrbE10 mutants (Fig 3A), this difference was not scored as significant using Angiotool.
In order to study the Nkx2-5 conditional mutant cardiac phenotype in more detail, we per-
formed immunofluorescence on transverse sections using WGA, a lectin used to quantify car-
diac fibrosis and cardiomyocyte size [27]. Extensive subendocardial fibrosis was detected in
Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 hearts while no evident signs of fibrosis were observed in
control mice (Figs 3D, S1D and S3). Interstitial fibrosis was quantified by measuring the per-
centage of fibrotic area in the LV and revealed a more extended fibrosis in Nkx2-5ΔTrbE10 than
Nkx2-5ΔTrbE14 mutant hearts (Fig 3F). WGA staining also revealed a hypertrophic phenotype
in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutants (Fig 3D-a,a’). The number of cardiomyocytes/
field is significantly reduced in these two mutants compared to control (Fig 3E). This hypertro-
phic phenotype is independent of Nkx2-5 expression as it was observed in both Nkx2-5-posi-
tive and Nkx2-5-negative, i.e. non-deleted as well as deleted cardiomyocytes (arrowheads in
Fig 3D-a’).
In summary, anatomical and morphological criteria demonstrate that conditional Nkx2-5
loss of function in Cx40 expressing trabecular myocardium results in excessive trabeculations.
This phenotype is accompanied by trabecular compaction defects including absence of papil-
lary muscle coalescence, deep protrusions of Endoglin+ cells resulting in endocardial islets,
hypoplasia of the PF network, extensive subendocardial fibrosis and cardiac hypertrophy.
magnifications of the left ventricular lumen show the numerous endocardial islets detected in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14
mutants (arrows). Scale bar = 100μm. (D) Perfusion of WGA-Cy3 lectin in the ventricle of control and Nkx2-5ΔTrbE10 hearts. (E)
Immunofluorescence with endoglin, VEGFR2 and perfused WGA to detect the endocardium. Scale bar = 1mm. Below, high
magnification of Eng+/VEGFR2- endocardial islets stained with perfused WGA-Cy3 (arrows). Scale bar = 100μm. (F-G)
Quantification of the degree of excessive trabeculations by measuring the total length of the endocardium layer. These measures were
performed for 3 sections at the level of the apex and at mid-ventricle from control (N = 3), Nkx2-5ΔTrbE10 ( p< 0,005, N = 3) and
Nkx2-5ΔTrbE14 (p< 0,05, N = 3) adult hearts (F), and counting the number of endocardial islets per section (G) (p< 0,002, N = 3
for Nkx2-5ΔTrbE10 vs control and $ p< 0,02, N = 3 vs Nkx2-5ΔTrbE14).
https://doi.org/10.1371/journal.pgen.1007502.g002
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Moreover, distinct severe and mild phenotypes were observed following Nkx2-5 deletion using
Cx40-cre at embryonic and fetal stages respectively, suggesting a relationship with the extent of
trabeculae-derived myocardium in which Nkx2-5 has been deleted.
Hypertrabeculation is associated with an upregulation of cardiac
proliferation without disturbing the compact-trabecular boundary at fetal
stages
To investigate the embryonic basis of the hypertrabeculated phenotype, we analyzed cardio-
myocyte mitotic activity in the left ventricle of E14.5 control and Nkx2-5ΔTrbE10 hearts by PH3
immunofluorescence on sections (Fig 4A and 4B). Quantification revealed a slight excess of
PH3+ nuclei in cardiomyocytes of mutant hearts, which is not restricted to the trabecular
zone, suggesting a global increase of proliferation in ventricular cardiomyocytes. Using
Cx40-Cre::R26-YFP genetic tracing of the same fetal hearts, we observed no difference in the
distribution of YFP+ cells in mutants in either atria and ventricles (Fig 4B). Moreover, in situ
hybridization using probes specific for the compact and trabecular zones, Hey2 and ANF
(Nppa) respectively, revealed the formation of a clear boundary in both E14.5 control and
Nkx2-5ΔTrbE10 hearts (Fig 4C). The compact-trabecular transition at fetal stages is thus unaf-
fected in mutant hearts, suggesting that the excessive trabeculation results from both defects in
cardiac proliferation and impaired ventricular compaction.
Hypertrabeculation after conditional Nkx2-5 loss of function is associated
with conduction defects and progressive HF correlated with strain defects
The above results show that conditional Nkx2-5 loss of function using Cx40-cre results in new
mouse models of severe and mild ventricular non-compaction. We next carried out a longitu-
dinal study of the same animals in order to document the evolution of the hypertrabeculated
phenotypes with age and the consequence of these morphological defects on cardiac function.
A follow up of cardiac morphology and function was performed in individual mice over a year
using cardiac MRI, echocardiography or ECG recordings.
In order to compare trabecular morphology in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutants,
we used high-resolution cine-MRI, a highly sensitive non-invasive imaging technique. High-
resolution cine-MR images revealed the presence of trabeculations in the LV of Nkx2-5ΔTrbE10
and Nkx2-5ΔTrbE14 mutants compared to the smooth endocardium observed in control hearts
(Fig 5A). These results are consistent with our histological findings (Figs 2B and S1). Follow-
up analysis of the same animals from 3 to 10 month-old showed indistinguishable cardiac
structures at all timepoints in term of number and size of papillary muscles or trabeculations,
suggesting no morphological evolution of the hypertrabeculated phenotype with age.
Fig 3. Ventricular conduction system defects, fibrosis and cardiac hypertrophy associated with Nkx2-5-induced hypertrabeculation. (A) Whole-
mount immunofluorescence with Contactin-2 on opened LV from control (Ctrl), Nkx2-5ΔTrbE10 (ΔTrbE10) and Nkx2-5ΔTrbE14 (ΔTrbE14) adult hearts.
High magnifications of peripheral PFs are shown below beside the corresponding images treated with angiotool. Red lines indicate the PF, and blue dots
the branch points. LBB: Left bundle branch; LFP: Left PFs. Scale bar = 1mm. (B-C) Quantification of PF (B) and branching density (C). (N = 3 hearts per
group) Mean ± SD; p<0.01 Nkx2-5ΔTrbE10 vs control, p<0.01 Nkx2-5ΔTrbE14 vs control. (D) Immunofluorescence with Contactin-2 and WGA-cy3
antibodies on transversal sections at the mid-ventricular level from control (Ctrl), Nkx2-5ΔTrbE10 (ΔTrbE10) and Nkx2-5ΔTrbE14 (ΔTrbE14) adult hearts.
Asterisks indicate papillary muscles. Scale bar = 1mm. (a-a’) High magnifications at the level of the interventricular septum (a) and a serial section
stained with WGA-cy3 and Nkx2-5 (a’). Dotted lines indicate the size of cardiomyocytes and arrowheads Nkx2-5- nuclei present only in Nkx2-5ΔTrbE10
and Nkx2-5ΔTrbE14 mutants hearts. Scale bar = 50μm. (E) Quantification of cardiomyocytes hypertrophy by counting the number of cardiomyocytes per
frame on high magnification images of transversal sections. (n = 20–30 frames per heart; N = 3 mice per group). p<0.002 Nkx2-5ΔTrbE10 and Nkx2-
5ΔTrbE14 vs control. (F) Fibrosis was quantified by measuring the percentage of WGA positive area in the LV. These measures were performed for 3
sections of adult hearts at the level of the apex and at mid-ventricle from control (N = 3), Nkx2-5ΔTrbE10 (p< 0,005 (apex) and p< 0,002 (mid) vs
control, N = 3) and Nkx2-5ΔTrbE14 ($ p< 0,02 (apex) and $$ p< 0,01 (mid) vs Nkx2-5ΔTrbE10, N = 3).
https://doi.org/10.1371/journal.pgen.1007502.g003
Developmental origins of pathological ventricular non-compaction
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Fig 4. Analysis of proliferation and the compact trabecular boundary in fetal mutant hearts. (A-B) PhosphoHistoneH3/Nkx2-5/YFP
immunofluorescence of left ventricular cardiomyocytes from E14.5 control and Nkx2-5ΔTrbE10 (ΔTrbE10) hearts. White and yellow arrows
indicate PH3+ cardiomyocytes and non-cardiomyocytes, respectively. The boundary between the trabecular and compact zones is indicated by
a dotted line. The graph shows the percentage of PH3+ cardiomyocytes per section and the percentage of these PH3+ cardiomyocytes in the
Developmental origins of pathological ventricular non-compaction
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However, several cardiac parameters measured from these MR images showed significant dif-
ferences between groups and/or age (Table 1). In the line with cardiac cell hypertrophy
observed in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutants, LV mass is increased, particularly in
Nkx2-5ΔTrbE10 hearts. At the functional levels the stroke volume is lower and the ejection frac-
tion (EF) is reduced in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 compared to control hearts revealing
trabecular zone. Quantification was performed on 3–4 sections per heart (N = 3); p<0.05 control vs Nkx2-5ΔTrbE10. Scale bar = 100μm. (C) In
situ hybridization using ANF (Nppa) and Hey2 riboprobes on left ventricular cardiomyocytes of E14.5 control and Nkx2-5ΔTrbE10 (ΔTrbE10) fetal
hearts. Scale bar = 200μm. Right: high magnifications of left ventricles. Scale bar = 100μm.
https://doi.org/10.1371/journal.pgen.1007502.g004
Fig 5. Longitudinal study of cardiac function by magnetic resonance imaging in Nkx2-5 conditional mutant mice. (A) Short-axis cine images
recorded by MRI at end-diastole (DIA) and end-systole (SYS). Images represent the follow-up of the same heart per mutant groups at 2–4, 6–8 and
9–10 month-old, with the yellow line indicating the endocardial outline and the blue line indicating the epicardial outline. Signs of hypertrabeculation
are highlighted by arrows, and papillary muscles by stars. (B) Boxplot graphs represent the evolution of the ejection fraction (EF) measured in the same
mice over a year. The EF corresponding to the LV capacity of contraction, was estimated by manually volumetric measurements from cine long and
short axis images. Each dot represents an individual mouse. Red and green dots represent mice associated with contraction defects and fluctuating EF
over time. (N = 6 in control and N = 7 for Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14). Defects in six-month old Nkx2-5ΔTrbE10 were significant vs control,
p = 0,0165.
https://doi.org/10.1371/journal.pgen.1007502.g005
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serious contractility defects (Fig 5B and Table 1). Interestingly, the individual follow-up
showed that several mutants exhibited fluctuating EF with age (red and green dots in Figs 5B
and S4); for example, an EF measured at 35% at 3 months, 33% at 6 and increased to 62% at 9
months in the same Nkx2-5ΔTrbE10 mouse. Movies created from short-axis cine series of these
different hearts show irregular deformations of the LV during cardiac cycles and reveal that
these defects are aggravated with age, revealing problems of contractility in these mutants (S1–
S4 Movies).
To better appreciate the myocardial deformation, we carried out speckle-tracking based
strain imaging analysis by echocardiography. At 3 months, longitudinal and radial strain mea-
surements in the long axis were identical in all mice while radial and circumferential strain
measurements in the short axis were elevated in Nkx2-5ΔTrbE10 hearts compared to control or
Nkx2-5ΔTrbE14 mutants (Fig 6A). In contrast, both Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutants
presented a decreased strain in all axes in old mice compared to age-matched control animals
(Fig 6B). These results highlight the defects of myocardial deformation, already detected in
young mice when the hypertrabeculation phenotype is most severe. In addition, the variation
of strain with age is consistent with the variability of EF measured in both mutants. Interest-
ingly, a number of mice with a severe or mild hypertrabeculation phenotype, presented signs of HF
with an EF<40% suggesting that altered cardiac function is independent of the level of excessive
trabeculation. Secondary to the HF phenotype, RV dysfunction was detected in 9 month-old Nkx2-
5ΔTrbE10 and Nkx2-5ΔTrbE14 mice but not in 3 month-old mice (S5 Fig). Moreover, both mutants
presented a reduced EF in old mice which is highly correlated with strain in all axes supporting the
fact that strain is a good parameter to estimate cardiac function and HF (Fig 6C).
Table 1. Characteristics and volumetric measurements from MRI.
2–3 month-old 6–8 month-old 9–10 month-old 2-way Anova




6 (5/1) 7 (7/0) 7 (4/3) 5 (4/1) 7 (7/0) 7 (4/3) 6 (5/1) 7 (7/0) 7 (4/3)
Body weight (g) 39,8 ± 3,6 39 ± 2,2 38 ± 2,9 45,7 ± 2,6 48,6 ± 2,6 42,4 ± 2,5 48,3 ± 3,3 54,3 ± 3,8 aa 46,4 ± 3,1 ¶¶¶ NS
Morphological parameters
EDV (μl) 61,2 ± 5,8 63,3 ± 2,1 50,1 ± 3,5 71,3 ± 6,9 64,4 ± 2,3 62,8 ± 9,3 75,5 ± 4 76,5 ± 7,7 69,7 ± 8,0 ¶ NS
ESV (μl) 17,7 ± 3,9 23,0 ± 2,5 17,7 ± 3,0 21,5 ± 3,6 30,0 ± 3,0 25,2 ± 7,1 24,7 ± 2,8 34,5 ± 8,4 32,5 ± 5,8 ¶ NS
LVmass (mg) 112,2 ± 6,0 132,2 ± 10,6 105 ± 5,1 118,5 ± 8,8 153,6 ± 17,5 125,4 ± 14,4 124,9 ± 10,3 177,7 ± 14,3;a 136,6 ± 14,3 ¶ ¶¶
sWTn (%) 46,8 ± 6,2 34,9 ± 4,3 36,1 ± 3,5 43,2 ± 3,9 31,7 ± 6,7 40,4 ± 5,1 47,7 ± 5,1 33,4 ± 5,9 31,6 ± 4,7 NS ¶
Functional parameters
EF (%) 66,7 ± 4,3 52,6 ± 3,7 58,3 ± 3,2 63,4 ± 3,1 44,9 ± 3,2 53,9 ± 4,9 59,3 ± 1,5 49,6 ± 8,3 46,0 ± 4,0 NS ¶¶
SV (μl) 43,5 ± 3,0 40,2 ± 2,4 32,4 ± 1,0 49,8 ± 4,8 34,4 ± 2,6  37,5 ± 3,1 50,8 ± 3,3 42,0 ± 2,0 37,2 ± 3,3  NS ¶¶¶¶
Normalized morphological
parameters
EDV (μl/g) 1,56 ± 0,15 1,65 ± 0,10 1,34 ± 0,11 1,52 ± 0,16 1,36 ± 0,11 1,47 ± 0,17 1,57 ± 0,04 1,45 ± 0,17 1,48 ± 0,08 NS NS
ESV (μ/g) 0,45 ± 0,11 0,62 ± 0,09 0,47 ± 0,09 0,46 ± 0,08 0,62 ± 0,07 0,58 ± 0,15 0,51 ± 0,05 0,66 ± 0,16 0,68 ± 0,08 NS NS
LVmass (mg/g) 2,89 ± 0,22 3,46 ± 0,36 2,84 ± 0,22 2,51 ± 0,15 3,21 ± 0,39 2,92 ± 0,23 2,59 ± 0,15 3,32 ± 0,29 2,90 ± 0,13 NS ¶
N = number of animals used in this study. ESV = End-Systolic Volume and EDV = End-Diastolic Volume, represent the internal volume of the left ventricle chamber at
the end of the systole or diastole; LV mass dia and LV mass sys, represent the mass of the left ventricular wall at the end of the diastole or systole; sWTn = systole Wall
Thickening, represents the thickening of the left ventricular wall at the end of the systole compare to the end of the diastole; EF = Ejection Fraction, represents the
percentage of volume measured at the end of the diastole, expulsed at the end of the systole; SV = Stroke Volume, represent the volume of blood expulsed at the end of
the systole. Data are expressed in Mean ± SE
P<0,05 vs control; P<0,01 vs control; aP<0,05 vs 3 months; ¶P<0,05; ¶¶P<0,01; ¶¶¶P<0,001; ¶¶¶¶P<0,0001.
https://doi.org/10.1371/journal.pgen.1007502.t001
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In parallel, we performed a longitudinal study in the same group of mice to investigate the
cardiac electrical activity by measuring surface electrocardiograms (ECGs). The analysis of ECG
traces revealed major defects in the QRS complex from 3 month-old in Nkx2-5ΔTrbE10 and
Nkx2-5ΔTrbE14 mutants (Fig 7A). Monophasic R and R’ waves were early observed in both
mutants and Notched R wave was first detected in Nkx2-5ΔTrbE10 mutant mice. Fragmented
QRS, the more drastic defect, was only recorded in Nkx2-5ΔTrbE10 mutant mice (Fig 7A). At 9
months, none of the Nkx2-5 mutants had a normal QRS in contrast with control mice that
never showed QRS defects. Analysis of time intervals and wave amplitudes is summarized in
Table 2. Consistent with observations of QRS shape, broader QRS intervals with smaller ampli-
tude of R waves were found in Nkx2-5ΔTrbE10 mutant and to a lesser extent in Nkx2-5ΔTrbE14.
These results illustrate bundle branch blocks (BBB) in both mutants. Moreover, QRS intervals
duration correlates fully with EF, measured by cardiac MRI and echography, and LV mass (Fig
7D). Indeed, animals with the lowest EF had the broadest QRS intervals. Note that only cardiac
activation was disturbed. The repolarization phase, represented by QT intervals and T wave
amplitude, was not impacted (Fig 7A and Table 2). Moreover, increased PR intervals, indicative
of 1st degree atrioventricular block in accordance with the atrial deletion of Nkx2-5, were evi-
denced as previously reported in Nkx2-5 mutants [10, 28]. Because ECGs were recorded under
anesthesia, the β1-agonist dobutamine (DOB) was used to challenge the hearts. Heart rate was
identical in all untreated animals (Table 2), and increased after treatment by 45 and 47% at 6
and 9 months respectively, in control. In contrast, Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutants dis-
played chronotropic incompetence after DOB injection; heart rate increased by only 15–21%
and 25–36% (in 6–9 month-old mice respectively) in line with a decreased cardiac reserve par-
ticularly in Nkx2-5ΔTrbE10 (Fig 7B and 7C). However, arrhythmia and a severe susceptibility to
ventricular fibrillation were unveiled in both mutants but not in control mice (Fig 7C).
Together, these data demonstrate that severe and mild hypertrabeculation phenotypes are
coupled with severe defects in cardiac activation and contractility. Hypertrabeculation associ-
ated with fibrosis, hypertrophy and Purkinje fibers hypoplasia is linked with early conduction
defects, leading progressively to strain defects and HF. This cardiac phenotype is similar in
both mutants, though delayed in Nkx2-5ΔTrbE14 mice.
Hypertrabeculation after conditional Nkx2-5 loss of function is supported
by transcriptional changes in developmental, functional and inflammatory
processes
In order to identify transcriptional changes associated with hypertrabeculation and functional
defects, we performed a microarray analysis on LV tissue including the ventricular free wall
and apex from Nkx2-5ΔTrbE10, Nkx2-5ΔTrbE14 and control adult hearts. Comparison between
both mutants and the control showed 622 differentially expressed probes, corresponding to
469 genes among the 39,430 mouse genes screened. A comprehensive list of the significantly
misregulated genes is presented in a supplementary file. The hierarchical clustering in both
dimensions (samples and genes) showed clear differences between the 3 groups (Fig 8A).
Seven clusters, from an unsupervised hierarchical clustering based on the similarities of
Fig 6. Early and late strain defects in Nkx2-5mutant hearts evaluated by high resolution echocardiography. (A) Histogram showing that
long-axis radial and longitudinal strains are similar in 3-month-old mice. (B) The short-axis radial strain is increased in 3-month-old Nkx2-
5ΔTrbE10 mice compared to control and Nkx2-5Δcomp mice. (p<0.01 Nkx2-5ΔTrbE10 vs control, $$ p<0.01 Nkx2-5ΔTrbE10 vs Nkx2-5Δcomp; N = 6).
(C-D) Long and short-axis strain parameters were decreased in 9-month-old Nkx2-5 mutant mice compared to control (p<0.001 Nkx2-
5ΔTrbE10 and Nkx2-5Δcomp vs control; N = 8–10 per groups). (E-F) Plots of Ejection Fraction (EF) against strain data recorded during long axis
(E) and short axis (F) from 9-month old mice. Linear relationships are observed and R2 and p-values are indicated for each graph. Red and
green dots represent mice with a fluctuating EF associated with strain defects.
https://doi.org/10.1371/journal.pgen.1007502.g006
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Fig 7. Hypertrabeculated Nkx2-5mutant hearts exhibit QRS defects, BB blocks and high susceptibility to fibrillation. (A)
Representative tracings from surface ECG measured in lead II in anaesthetized mice at 3-, 6- and 9-month old. In control mice, QRS
complexes are normal regardless of the age at which they were recorded. Tracings from Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mice
demonstrated bundle branch block-like appearance with widened QRS complex and a characteristic pattern with Notched R, R’
wave and fragmented QRS. (B) Dobutamine caused a marked increase of heart rate in control mice and only a small effect in Nkx2-
5ΔTrbE10 and Nkx2-5ΔTrbE14 mice. (C) Severe susceptibility to ventricular fibrillation was found in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14
mutants but not in control mice. Cardiac frequency and quantification of arrhythmias and fibrillation before and after Dobutamine
injection are summarized in the table. (D) Plots of QRS duration in lead II from 9-month old mice against Ejection Fraction (EF)
recorded during echocardiography (N = 27) and MRI (N = 11) or against LV mass from MRI (N = 11). Red and green dots represent
mice with fluctuating EF overtime. Linear relationships were observed and R2 and p-values were indicated for each graph.
https://doi.org/10.1371/journal.pgen.1007502.g007
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expression, were analyzed using Gene Ontology (GO). The most significant Biological Pro-
cesses (BP) are associated with cardiovascular development, differentiation, inflammation,
apoptosis and ionic transport (Fig 8A) and totally support the morphological and functional
data. Major genes known for their role in LVNC or other cardiomyopathies and genes previ-
ously reported in Nkx2-5 mutants were found to be deregulated in both mutants (Fig 8A).
Comparison of gene profiles revealed that conditional inactivation of Nkx2-5 in ventricular
trabeculae at embryonic stage resulted in the deregulation of many more genes than at fetal
stage: 601 vs 349 respectively, 26% of which were common, as shown on the Venn diagram in
Fig 8B and in the lists of the supplementary file. Specifically up-regulated genes after Nkx2-5
deletion vs control were twice as numerous as down-regulated genes in Nkx2-5ΔTrbE10 adult
hearts, 64% of which were up-regulated and 36% down-regulated. In Nkx2-5ΔTrbE14 hearts,
84% of them were up-regulated by the deletion of Nkx2-5 at fetal stage while 16% were down-
regulated (Fig 8B). Interestingly, GO analysis of differentially expressed genes revealed that the
same biological processes were involved in both mutants but the number of genes within each
process was greater in Nkx2-5ΔTrbE10 hearts. Therefore these data confirm that Nkx2-5 deletion
is associated with substantial transcriptional changes causing a deep remodeling of the heart,
and are consistent with the observation of a stronger phenotype in Nkx2-5ΔTrbE10 hearts.
In order to obtain a comprehensive overview of biological processes associated with hyper-
trabeculation after Nkx2-5 deletion, an integrative network was created with cytoscape (Fig
8C). While most of the BP were common to both embryonic and fetal deletions, a few path-
ways related to cardiac morphogenesis and cell adhesion were specific to Nkx2-5ΔTrbE10 mutant
while Nkx2-5ΔTrbE14 was associated with cardiac differentiation and hypertrophy terms.
Moreover, the majority of genes were transcription factors (TF) involved in a variety of
developmental processes. This network illustrates clearly the impact of Nkx2-5 deletion on fun-
damental processes including morphogenesis and cell differentiation.
Table 2. Surface ECG parameters.
3 month-old 6 month-old 9 month-old 2-way Anova
Groups Ctrl ΔTrbE10 ΔTrbE14 Ctrl ΔTrbE10 ΔTrbE14 Ctrl ΔTrbE10 ΔTrbE14 Age Group
N (males/females) 10 9 8 9 9 8 10 9 8
Heart Rate (BPM) 531 ± 34 481 ± 23 503 ± 23 486 ± 25 490 ± 28 451 ± 19 498 ± 26 509 ± 14 459 ± 24 NS NS
PR (msec) 33,1 ± 0,7 36,9 ± 1,1 32,3 ± 1,2 31,8 ± 1,0 39,9 ± 1,6

36,7 ± 2,0 34,2 ± 1,2 38,3 ± 1,3 36,9 ± 1,2 NS ¶¶¶¶
QRS (msec) 17,7 ± 0,2 21,1 ± 0,9

19,2 ± 0,8 17,7 ± 0,4 20,8 ± 1,2  19,8 ± 0,7 17,7 ± 0,2 22,9 ± 1,0

21,1 ± 0,8  NS ¶¶¶¶
QRS lead III
(msec)
11,7 ± 0,3 14,2 ± 0,7

12,7 ± 0,3 11,9 ± 0,2 12,7 ± 0,6 13,6 ± 0,5 11,5 ± 0,3 13,8 ± 0,6  13,7 ± 0,7  NS ¶¶¶¶
QT (msec) 41,8 ± 0,6 47,4 ± 2,0 43,1 ± 1,2 44,1 ± 1,2 45,1 ± 1,2 46,0 ± 3,5 47,0 ± 2,1 51,7 ± 2,9 46,0 ± 1,7 NS NS
T (mV) 66,1 ± 10,6 69,1 ± 8,8 96,3 ± 14,6 90,2 ± 11,9 101,7 ± 12,1 86,1 ± 15,4 88,6 ± 9,1 103,8 ± 11,1 83,1 ± 14,9 NS NS
QRS (mV) 860,5 ± 85,6 668,3 ± 95,9 832,5 ± 126,8 872,2 ± 65,1 722,2 ± 132,2 753,1 ± 124,5 805,5 ± 70,9 603,3 ± 57,7 693,1 ± 67,0 NS NS
T/QRS (%) 7,2 ± 0,9 11,3 ± 1,3 12,0 ± 1,8 10,1 ± 1,4 16,5 ± 2,5 11,4 ± 1,3 10,9 ± 0,7 18,1 ± 2,4 ; a 12,3 ± 2,3 ¶ ¶¶¶
S (mV) 192,5 ± 11,1 220,0 ± 68,6 223,1 ± 58,0 188,9 ± 21,7 180,6 ± 47,3 192,5 ± 42,3 155,5 ± 30,5 146,1 ± 27,7 173,8 ± 47,5 NS NS
T/S (%) 33,4 ± 4,9 47,6 ± 9,2 69,2 ± 22,4 63,1 ± 18,2 98,7 ± 31,0 65,1 ± 17,5 83,8 ± 17,7 152,0 ± 67,1 112,8 ± 40,0 ¶ NS
R (mV) 668,0 ± 77,2 448,3 ± 63,3 609,4 ± 104,7 683,3 ± 68,2 541,7 ± 91,1 560,6 ± 116,4 650,0 ± 56,4 457,2 ± 47,4 519,4 ± 85,2 NS ¶
T/R (%) 9,2 ± 1,1 16,6 ± 1,6 19,5 ± 5,8 12,7 ± 1,8 21,2 ± 2,7 17,0 ± 2,1 13,5 ± 0,6 23,7 ± 2,8 17,5 ± 3,6 NS ¶¶¶
N = number of animals used in this study. All parameters were recorded in lead II except for QRS in Lead III as indicated. Data are expressed in Mean ± SEM
P<0,05 vs control; P<0,01 vs control; P<0,001 vs control; P<0,0001 vs control; aP<0,05 vs 3 months; ¶P<0,05; ¶¶¶P<0,001; ¶¶¶¶P<0,0001.
https://doi.org/10.1371/journal.pgen.1007502.t002
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To validate the microarray data, we performed qPCR experiments for 14 genes that were
among the most up- or down-regulated genes, selected on the basis of their cardiovascular-
related function. Among the up-regulated genes in Nkx2-5ΔTrbE10 vs control, v-Maf and Six1
transcripts were quantified and Prkcz as a down-regulated gene. Mcpt4 was investigated as an
up-regulated gene in Nkx2-5ΔTrbE14 vs control hearts. We also analyzed genes in the common
part of the Venn diagram including Bmp10, Timp1, Cd207,Vsig4, Myh7, Vav-1, Rorb, Gcgr and
Vgll2 that are up-regulated in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 vs control hearts. RT-PCR anal-
ysis confirmed the microarray results with regard to fold-changes and significance and
highlighted the important differential expression of Six1 between Nkx2-5ΔTrbE10 and Nkx2-
5ΔTrbE14 mutants (Fig 9A). We further investigated this using a Six1-LacZ reporter line [29]. X-
gal staining in the LV was restricted to the compact zone in control mice while the staining
was increased and extended to the trabecular zone in Nkx2-5ΔTrbE10 mutant mice (Fig 9B).
Pecam1 co-immunostaining revealed previously unreported Six1 expression in endothelial
cells as well as in cardiomyocytes with high density of positive cells in the compact zone of con-
trol hearts (Fig 9C1-3). In Nkx2-5 conditional mutant hearts, an excessive number of β-gal pos-
itive cells, i.e. cardiomyocytes and endothelial cells was observed in the entire ventricular wall
(Fig 9C1-3). This result validated the up-regulation of Six1 in Nkx2-5 loss of function hypertra-
beculated hearts.
Together, our results show that deletion of Nkx2-5 using Cx40-cre at embryonic and fetal
stages disturbs the normal development and differentiation of the cardiovascular system.
Moreover, Nkx2-5 deletion in ventricular trabeculae provokes more molecular disturbances in
adult hearts when it occurs at embryonic rather than fetal stages. Nevertheless, the same BP are
affected in both cases, fully supporting the morphological and functional defects documented
in these hypertrabeculated hearts. Interestingly, Six1 expression is found in the trabecular zone
only in hypertrabeculated hearts suggesting that Six1 is a potential genetic marker of LVNC.
Discussion
In this study, we have analyzed the pathological consequences of excessive ventricular trabecu-
lation, induced by spatio-temporal deletion of Nkx2-5 during trabecular development, on
adult cardiac function. The loss of Nkx2-5 at embryonic stages resulted in a severe hypertrabe-
culated phenotype associated with excessive subendocardial fibrosis, while these phenotypes
were milder when deletion of Nkx2-5 occurred at fetal stages. Our analysis revealed that the
excessive trabeculation phenotype is more severe when Nkx2-5 deletion occurs at embryonic
rather than at fetal stages, consistent with progressive reduction of Cx40-derived trabecular
cell incorporation in the myocardial wall during ventricular morphogenesis [16]. Moreover,
Fig 8. Hypertrabeculated Nkx2-5mutant hearts suffered transcriptional changes in developmental, functional and inflammatory
processes. (A) 2D Hierarchical clustering of differentially expressed genes (Significance Analysis of Microarrays (SAM) 3 classes,
10,000 permutations, FDR< 0,05, TMeV) shows clearly the 3 differentiate groups corresponding to Control, Nkx2-5ΔTrbE10 and Nkx2-
5ΔTrbE14 6 month-old mutant mice (N = 4 per group). Enriched Biological Process (BP)-GO terms for the 7 clusters are indicated and
representative genes (selected for their role in cardiomyopathies or described in Nkx2-5 mutants) are noted. (B) Venn diagrams show
the number of genes significantly up- and down-regulated in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutants vs control mice (SAM 2
classes, FDR< 0.05, TMeV). Note that specifically up-regulated genes are twice numerous than the down-regulated genes and that the
number of genes deregulated in Nkx2-5ΔTrbE10 mutant is much greater than in Nkx2-5ΔTrbE14 mutant (592 vs 344). A gene ontology
analysis realized with David Database is reported on the graph in which the most significant representative BP are indicated. For all
processes, the number of genes deregulated in Nkx2-5ΔTrbE10 mutant is much greater than in Nkx2-5ΔTrbE14 mutant. (C) Gene network
diagram carried out with venn diagram genes whose fold change is 2. Blue rectangles correspond to the most significant BP found
in Nkx2-5ΔTrbE10 mutant and green rectangles, BP found in Nkx2-5ΔTrbE14 mutant. A vast majority of the most significant BP were
jointly found in both mutants and are colored in blue/green (David Database, P-Benjamini<0.05). Genes implicated in these
pathways are indicated in blue when they are specific for Nkx2-5ΔTrbE10, in green for Nkx2-5ΔTrbE14 mutant and in black when they are
common. Red circles indicate genes validated by qPCR.
https://doi.org/10.1371/journal.pgen.1007502.g008
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Fig 9. Molecular markers associated with hypertrabeculated Nkx2-5mutant hearts and mouse models of pathological LVNC. (A) Quantitative real-time PCR
performed for a list of selected genes. The housekeeping gene used was RPL32. (B-C) X-gal (B) and Pecam-1 (C) co-immunostaining on transversal sections of the
mid-ventricle from Six1LacZ/+::Nkx2-5+/+ and Six1LacZ/+::Nkx2-5ΔTrbE10 adult hearts. Dotted lines indicate the boundary between the trabecular and compact zone of
the left ventricular myocardium; asterisks, the papillary muscles (PM); arrows, β-positive cardiomyocytes; arrowheads, β-gal-positive endothelial cells. (C1-C3) High
magnifications of boxes at the level of the PM (C1), the trabecular/compact boundary (2) and the epicardium (3) on the LV. Scale bar B = 1mm; C = 100μm; C1-
3 = 50μm. (D) Mouse models of mild and severe hypertrabeculation associated with pathological features including intertrabecular recesses, non-compacted
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this phenotype was stable in old mice, suggesting that the level of hypertrabeculation is associ-
ated with the broader extension of Nkx2-5 deletion in the ventricular myocardium rather than
with aging. Another feature linked to hypertrabeculation was the subendocardial fibrosis
observed in Nkx2-5 conditional mutant hearts. This result is in agreement with a recent report
that subendocardial fibrosis is commonly observed in LVNC patients [30]. As in the case of
hypertrabeculation, subendocardial fibrosis is more pronounced in Nkx2-5ΔTrbE10 compared
to Nkx2-5ΔTrbE14 hearts. This is consistent with previous studies showing the absence of fibrosis
in hearts after conditional knockout of Nkx2-5 after mid-gestation, at perinatal or postnatal
stages [31, 32]. We observed that numerous genes associated with fibrosis are specifically upre-
gulated in the LV after embryonic deletion of Nkx2-5 and less affected at fetal stages. Together,
these data strongly suggest that subendocardial fibrosis originates from an early event due to a
dysfunction of ventricular trabeculae development rather than as a consequence of aging, as
has been suggested in human patients [30]. This data is of major interest as subendocardial
fibrosis may contribute to altered longitudinal and axial contraction, measured in strain analy-
sis, and to BBB and fibrillation [33–35]. Our mouse models of hypertrabeculation thus mirror
the clinical situation and support the conclusion that the degree of non-compaction results pri-
marily from developmental defects.
Ventricular compaction is a poorly understood step of cardiac morphogenesis. Using two
independent genetic tracing mouse models, it has been recently demonstrated that embryonic
cardiomyocytes of the trabecular or the compact zone mix in a hybrid zone, which covers a
large proportion of the compact myocardium in the adult heart [36]. Abolishing proliferation
in the compact zone leads to a hypertrabeculation phenotype that is not observed if prolifera-
tion is altered in the trabecular zone only [36]. These data suggest that non-compaction arises
as a result of proliferation defects of cardiomyocytes in the compact zone. Several other mouse
models including the ventricular Nkx2-5-conditional deletion support this assumption; how-
ever, most of these mutants present a very thin compact layer and are embryonic lethal [10,
13]. In contrast, in our Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutant hearts, hypertrabeculation
was not associated with a reduction of the compact layer. However, we were able to reproduce
excessive trabeculation by the conditional deletion of Nkx2-5 in ventricular trabeculae demon-
strating that disruption of trabecular development represents another mechanism leading to
hypertrabeculation. Moreover, our data suggest that hypertrabeculation results primarily from
trabecular coalescence defects. This model is supported firstly by the disruption of the molecu-
lar boundary between the trabecular and compact zone shown by Six1 misexpression, which
has been recently associated with right ventricular associated hypertrabeculation and fibrosis
in other mouse mutants [37, 38]. While this compact-trabecular transition initiates normally
in our mutants at fetal stages, proliferation defects may compromise late development of tra-
becular compaction. Secondly, the numerous endocardial islets detected in Nkx2-5ΔTrbE10
mutants are highly similar to the intertrabecular spaces connected to the LV observed in
LVNC patients [3]. This endocardial phenotype suggests a defect in the formation of coronary
vasculature from the endocardium that normally occurs at perinatal stages [24]. Moreover,
concomitant to the compaction step, the acquisition of a spiral pattern of cardiomyocytes
develops as a prerequisite for twisting contraction [2, 39]. Our strain analysis points out
important defects in myocardium deformation in hypertrabeculated hearts suggesting that
compaction defects plays a role later for the efficiency of cardiac contractions. All these results
papillary muscles, fibrosis and VCS hypoplasia. The degree of hypertrabeculation is relative to the extent of trabecular zone affected. The follow-up of cardiac
function shows a correlation of impaired Ejection Fraction with conduction and strain defects in absence of aggravation of the hypertrabeculation phenotype with
age. HF: Heart failure.
https://doi.org/10.1371/journal.pgen.1007502.g009
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highlight the role of Nkx2-5 in the complex modifications in ventricular morphology that take
place during trabecular compaction and their requirement for normal cardiac function.
A major characteristic of our Nkx2-5-hypertrabulated mouse models is the occurrence of
the numerous cardiac complications such as conduction blocks, contraction defects and HF,
often associated with LVNC in symptomatic patients. Because mutations in NKX2-5 are asso-
ciated with a myriad of congenital heart diseases (CHD) in humans, this transcription factor
has received much attention for its role in cardiac morphogenesis [20]. The atrial-specific
knockout of Nkx2-5 produced atrial hyperplasia, atrial septal defects and bradycardia [40]. In
comparison, deletion of Nkx2-5 in atrial myocardium induced by the Cx40-creERT2 line is het-
erogeneous and gives rise only to a modest effect such as a slight increase of the PR interval; in
particular, no atrial anatomical defects or reduced heart rate were detected in our mutant
mice. Moreover, a direct role of Nkx2-5 on cardiac contractility has already been described.
Indeed, reduced and irregular ventricular contractions are recorded by echocardiography in
newborn mice after conditional deletion of Nkx2-5 at E13.5 [32]. In these mouse models,
Nkx2-5 perturbs calcium handling and sarcomere organization, which are known trigger to
reduce contractility [10, 17, 31, 41]. In Nkx2-5 hypertrabeculated hearts, we found numerous
deregulated genes, involved in calcium signaling (Ryr2, Sln or SERCA2), the contractile appara-
tus (Myh7, Tnnt2), transmembrane ionic channels (HCN1, HCN4, Scn5a, Cacna1g, Cacna1h,
Kcne1), and cardiac development, including genes of the Notch pathway and its targets,
(Notch3, Dll1, Dtx1, Hey1, BMP10) (transcriptomic analysis and qPCR experiments (S6 Fig)).
These genes have been previously described to be deregulated in different Nkx2-5 mutant mice
and in some cases, including Myh7, HCN4 [32], Tnnt2 [42], Scn5a [43], Ryr2 [44] and Notch
signaling [9], have been associated with LVNC. It has recently been shown that cardiac con-
tractility may also depend directly on endothelial signaling through the NRG-1/Erbb2 path-
ways [45]. Indeed, Pecam-1 null mice display a slight decreased EF without morphological
defects in cardiomyocytes or capillary densities but resulting from a disturbed communication
between endothelial cells and cardiomyocytes. In our study, hypertrabeculated hearts present
vascular defects including endocardial islets, which correlate with upregulation of Endoglin
transcript levels. Indeed, LVNC patients are known to present defects in cardiac perfusion and
embolic thrombosis is a pathological feature of non-compaction cardiomyopathy [46, 47].
This is consistent with the microarray data in which genes involving endothelial cells signaling
or vasculature are found deregulated in mutant hearts. Finally, these changes in gene expres-
sion are likely to modulate cardiomyocyte activity that impact directly on cardiac contractility
and pump function as measured by reduced strain rate in line with decreased EF. Intriguingly,
we found fluctuations in strain and EF at different ages during the follow-up of the cardiac
function in few hypertrabeculated hearts. Recently, an “undulating” phenotype in which the
associated cardiomyopathic features change has been evocated in children with LVNC [3, 48].
For instance, a dilated and hypertrophic presentation with poor cardiac function changed to a
hypertrophic, hypercontractile form of non-compaction and the final destination was dilated
dysfunctional form of non-compaction with HF [49]. These observations highlight the
extreme variability in contractility of hypertrabeculated hearts and argue in favor of an inde-
pendent form of cardiomyopathy. The measurements of strain in LVNC patients confirm that
cardiac deformation represents a valuable parameter for prognosis in cases of excessive trabe-
culations [50].
We documented the first longitudinal study of the conduction defects in a mouse model
with hypertrabeculation. In our Nkx2-5 hypertrabeculated hearts, a total or quasi-absence of
PF is observed and these mice display early conduction defects, in particular LBBB consistent
with this hypoplasia phenotype. Indeed, PF connect to the sub-endocardium at Purkinje-mus-
cle junctions sites in humans to form the origin of myocardial activation [51]. Consistent with
Developmental origins of pathological ventricular non-compaction
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007502 July 6, 2018 21 / 31
our results, disruption of the spatiotemporal expression of ion channels has been shown to
induce defective propagation of impulse from endocardium to epicardium, resulting in BBB
and leading to increased susceptibility to fibrillation [52]. However, these ventricular conduc-
tion defects worsened during aging suggesting that QRS shape and duration also depend on
other parameters such as fibrosis and hypertrophy, which are known to impair conduction. To
support this hypothesis, we found a correlation between LV mass and QRS duration. While
the exact role of Nkx2-5 in ventricular conduction system development is unknown, numer-
ous genetically modified mouse models have revealed the importance of this transcription fac-
tor for normal cardiac conduction at postnatal stages [8, 31, 32, 53]. Hypoplasia of the
ventricular conduction system has not been reported in other mouse models of non-compac-
tion or in human samples suggesting that this phenotype may be specific to this transcription
factor [9, 54]. However, the presence of LVNC is significantly associated with a rapid deterio-
ration of LV function and higher mortality when associated with abnormal ECG measure-
ments [55]. Finally, we observed that hypertrabeculated hearts have impaired chronotropic
competence and are susceptible to ventricular fibrillation under conditions of stress. This is
consistent with the appearance in LVNC patients of complications such as exercise intolerance
or sudden death linked to excessive trabeculation in athletes after extensive exercise [2, 3]. Our
mouse data mirror the heterogeneity of the pathological outcomes among LVNC patients and
suggest that LVNC has a higher incidence of cardiac death when associated with cardiac dys-
function and arrhythmias. Furthermore, these data highlight the importance of Nkx2-5 in the
development of the ventricular conduction system and the role of these defects in the patho-
logical outcome of LVNC.
Our molecular analysis identified numerous genes related to cardiac dysfunction, and high-
lights the pleiotropic roles of Nkx2-5 during trabecular development. Among those genes, we
observed differential upregulation of Six1 between the Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14
mutants suggesting a role of this factor in the severity of the hypertrabeculated phenotype.
Six1 is a transcription factor identified for its role for skeletal muscle and cardiac progenitor
cell development [29, 37]. Our immunohistological analysis revealed upregulated Six1 expres-
sion in endothelial cells and cardiomyocytes of the trabecular zone, suggesting that deregula-
tion of this gene is associated with cardiac pathology rather than being a direct target of Nkx2-
5. Interestingly, Six1 has been recently found to be deregulated in cardiomyopathy induced by
Nkx2-5 point mutation or in human patients [56, 57]. Our data suggest that Six1 may be a
good marker for pathological forms of excessive trabeculation in non-compaction
cardiomyopathy.
Conclusion
In conclusion, impaired trabecular compaction provokes a hypertrabeculated phenotype asso-
ciated with a disturbed endocardial vasculature, VCS hypoplasia and subendocardial fibrosis
(Fig 9D). Our data strongly suggest that complications associated with hypertrabeculation
such as cardiac hypertrophy and HF arise progressively and may be a direct consequence of
the conduction defects and abnormal cardiac contractility of hypertrabeculated myocardium.
Interestingly, these mice present a progressive impaired cardiac function while excessive trabe-
culations are morphological identical throughout adult life, supporting the idea that this
anomaly does not per se trigger the pathology in LVNC. This study clarifies the origin of the
pathological outcomes associated with LVNC and, although further developments are clearly
warranted, may provide helpful information for clinicians in the future for the diagnostic and
prognostic evaluation of left ventricular non-compaction patients.
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Materials and methods
Generation of mouse models
Animal procedures were approved by the ethics committee for animal experimentation of the
French ministry (n˚ 01055.02). Cx40-creERT2, R26-YFP and Six1-LacZmouse lines were geno-
typed as previously reported [21, 29, 58]. A conditional null allele of Nkx2-5was generated as
described (Nkx2-5flox) [22]. To remove the Frt-flanked neomycin cassette present in this allele,
Nkx2-5floxmice were bred with a ubiquitous flipase mouse line (ACTB:FLPe) [59]. The Floxed-
Nkx2-5-ΔNeo allele was used in the subsequent breedings with the Cx40-creERT2 mouse line. To
delete the Floxed-Nkx2-5-ΔNeo gene, tamoxifen was injected intraperitoneally to pregnant females
(200μl) for two consecutive days. Tamoxifen (T-5648, Sigma) was dissolved at the concentration
of 20mg/ml in ethanol/sunflower oil (10/90). After tamoxifen treatment of pregnant females, new-
born mice were recovered by caesarian section and given for adoption to CD1 females. Fifty mice
were assigned to three groups: Nkx2-5ΔTrbE10 mice received tamoxifen injections at embryonic
stages (E10.5 and E11.5), Nkx2-5ΔTrbE14 mice received tamoxifen injections at fetal stages (E13.5
and E14.5), and control mice are littermates with Nkx2-5-ΔNeofl/fl:Cx40+/+ genotype.
Macroscopic and histological analyses
Macroscopic examination of the internal surface of the ventricles was previously described [60].
For histological studies, adult hearts were dissected, fixed for four hours in 4% paraformaldehyde
(vol/vol) in PBS, washed in sucrose gradient, then embedded in OCT and cryosectioned. To quan-
tify interstitial fibrosis, transverse sections were counterstained with wheat germ agglutinin-Cy3
(WGA-Cy3 from Sigma-Aldrich) as described previously [27]. For immunofluorescence, sections
were permeabilized in PBS 1X / 0.2% Triton X100 for 20 min and incubated for 1 hour in satura-
tion buffer (PBS 1X / 3% BSA / 0.1% Triton X100). Primary antibodies were incubated in saturation
buffer overnight at 4˚C. Secondary antibodies coupled to fluorescent molecules were incubated in
saturation buffer and after washes, hearts were observed under a Zeiss Apotome microscope.
For whole-mount immunofluorescence, adult hearts were pinned on petri dish to expose
the LV and fixed in 4% paraformaldehyde for 2 hours at 4˚C, washed in PBS, permeabilized in
PBS 1X / 0.5% Triton X100 for 1h and incubated for 3 hours in saturation buffer (PBS 1X / 3%
BSA / 0.1% Triton X100). The primary antibodies were incubated in saturation buffer for 24
hours at 4˚C. Secondary antibodies coupled to fluorescent molecules were incubated in satura-
tion buffer and after washes, hearts were observed under a Zeiss LSM780 confocal microscope.
The measure of the endocardial length (mm) was carried out using Image J software by
drawing the contour of the endocardium (Eng1+/VEGFR2-) lining the LV on transversal sec-
tions and the mean of 3 sections per heart was calculated (n = 3 mice of each group). The num-
ber of PH3+ cells per LV section was quantified using Zeiss Zen software from LSM780
confocal images. The PH3+ cardiomyocytes are stained for Nkx2-5+ or YFP+. The percentage
of PH3+ cardiomyocytes over the number of PH3+ cells was calculated from the total number
of cells of 3–4 sections per heart (n = 3 embryos of each group).
Antibodies used in this study are specific to Nkx2-5 (Sc8697 Santa-Cruz), GFP (AbD Sero-
tec), RFP (Rockland), Contactin-2 (AF1714 R&D system), Pecam-1 (MEC13.3-BD Pharmin-
gen), Endoglin CD105 (MJ7/18-DSHB), VEGFR2 (AF644-R&D SYSTEMS), α-Smooth
Muscle Actin (F3777-SIGMA).
Ex-vivoperfusion in the LV of the lectin WGA-Cy3
After dissection, adult hearts were rapidly intubated with a 24G Surflo IV catheter in the aortae
and perfused with 1ml of PBS heparin to remove blood, then 200μl of WGA-Cy3 was
Developmental origins of pathological ventricular non-compaction
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007502 July 6, 2018 23 / 31
introduced in the LV through the same catheter and incubated for 30 minutes before fixation
in 4% PFA. After fixation, hearts are processed as described above.
In situ hybridization
Non-radioactive in situ hybridization on sections from E14.5 hearts were performed as
described [61] using Hey2 and ANF mRNA probes.
Cardiac magnetic resonance imaging (MRI)
MRI was carried out every two months on the same animal groups from 2 to 12 months-old mice.
The experiments were performed on a Bruker Biospec Avance 4.7 T/30 imager (Bruker Biospin
GmbH, Ettlingen, Germany) (France Life Imaging network), as previously described [62]. Anes-
thesia was maintained during MRI with 1.5–2% Isoflurane in a constant flow of room air (270 ml/
min) through a nose cone using a dedicated vaporizer (univentor anaesthesia unit, univentor high
precision instrument Zejtun, Malta). Temperature was maintained at 39˚C. Breath and heart rate
were monitored and signals were used to trigger MRI acquisition using a monitoring and gating
system (SA Instruments, Inc. Stony Brook, NY, USA). Cine-MRI (ECG gating, repetition time 5
ms, echo time 1.51 ms, flip angle 20˚, slice thickness 1 mm, pixel size 0.195×0.195 mm2) were per-
formed in short axis view. Ten phases per heartbeat were acquired from base to apex to cover the
whole LV. In addition, one high resolution cine series (ECG gating, repetition time and frame rate
15 ms, echo time 1.68 ms, flip angle 30˚, slice thickness 1.1 mm, pixel size 0.086×0.086 mm2) was
acquired in short axis view at the mid base-apex location to evaluate trabecular morphology.
Surface electrocardiography
Surface ECGs were performed on anesthetized mice. An induction with 5% isoflurane was fol-
lowed by maintenance at 1 to 2% in a constant flow of oxygen at 700 ml/min. ECGs were
recorded every two months from 2 to 12 months using a bipolar system in which the electrodes
were placed subcutaneously at the right (negative) and left forelimb (reference) and the left
hindlimb (positive) for lead II and at the right (reference) and left forelimb (negative) for lead
III. Electrodes were connected to a Bioamp amplifier (AD Instruments) and were digitalized
through an A/D converter ML 825 PowerLab 2/25 (AD Instruments). Digital recordings were
analyzed with Chart software for windows version 5.0.2 (AD Instruments). Events were regis-
tered to 100 K/s and were filtered to 50 Hz. ECG recordings were obtained for 1 min after sta-
bilization of the signal. Post-analysis was performed for heart rate, PR, QRS, QT intervals, T, R
and S durations, T, R, S and QRS amplitudes.
A Dobutamine (DOB) stress-test was performed on selected 6 and 9 month-old mice. After
recording of ECG as described above, mice received an intraperitoneal single injection of DOB
at a dose of 0,75 μg/g body weight or an equivalent volume of vehicle (0,9% NaCl). The DOB
dose was selected after a bibliographic study on the criteria of a moderate increase of heart rate
and a preliminary experiment using the dose of 0,75 μg/g in which two volumes of injection
were tested. The lowest volume was chosen and DOB was prepared as follows:
DOB hydrochloride powder (Sigma-Aldrich, product number D-0676) was dissolved in
ddH2O and vortexed to provide a 10 mg/ml DOB stock solution. DOB working solution
(0,1 μg/μl) was prepared by 1:100 dilution of the stock solution in sterile 0,9% NaCl.
Echocardiography
Echocardiography was performed using a Vevo 2100 ultrasound system (VisualSonics,
Toronto, Canada) equipped with a real-time micro-visualization scan head probe (MS-550D)
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operating at a frame rate ranging from 740 frames per sec (fps). Mice were anesthetized with
isoflurane (IsofloH, Abbott S.A, Madrid, Spain) at a concentration of 3.5% for induction and
between 1 to 1.5% for maintenance during the analysis with 100% Oxygen. Each animal was
placed on a heated table in supine position with extremities attached to the table through four
electrocardiographic leads. The chest was shaved using a chemical hair remover (Veet, Reckitt
Benckise, Granollers, Spain). Ultrasound gel (Quick Eco-Gel, Lessa, Barcelona, Spain) was
applied to the thorax surface to optimize the visibility of the cardiac chambers. The heart rate
(HR) and respiratory rate of mice were recorded during the echocardiographic study. Two
mice were excluded from the study due to very low HR. Echocardiograms were acquired at
baseline. Left ventricular (LV) characteristics were quantified according to the standards of the
American Society of Echocardiology and the Vevo 2100 Protocol-Based Measurements and
Calculations guide, as described in the following paragraphs. LV diameters were measured on
a two-dimensional (B-mode) parasternal long axis and short axis view. The functional parame-
ters of the heart were evaluated based on LV diameter measurements.
Microarrays
Total RNA was isolated from LVs (left ventricular wall with apex and without the interventric-
ular septum) of 6 month-old control, Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mice (n = 4 for each
group) using TRIzol Reagent according to the manufacturer’s procedure (Invitrogen, Life
Technologies). The concentration of RNA was determined by reading absorbance at 260 nm
on NanoDrop (ND-1000, ThermoScientific). The quality of RNA was confirmed on the Agi-
lent 2100 Bioanalyzer (Agilent technologies, Germany) with the Agilent RNA 6000 Nano
chips. The samples with the RIN (RNA Integrity Number) closed to 10 were used for microar-
ray. The SurePrint G3 Mouse GE8x60K Microarray Kit (Agilent Technologies, Santa Clara,
CA) containing 62 976 oligonucleotide probes representing 39 430 genes was used. Quantile
normalization was applied to sample data to correct for global intensity and dispersion. Then,
a filtering at 75% was used to keep only genes expressed over the background noise, so 22 114
probes. A Significant Analysis of Microarray (SAM) 3 classes, with 10 000 permutations was
applied with a False Discovery Rate (FDR) at 5% to look for mutant specific variation in gene
expression in the dataset. Hierarchical clustering of the differentially expressed genes was
obtained with TM4 Microarray Software Suite V4.9 (https://www.tm4.org) using average link-
age clustering metrics and Pearson correlation for the distance. We identified enriched func-
tional annotations for the clusters using DAVID Bioinformatics Resources 6.7 (https://david.
ncifcrf.gov). A SAM 2 classes with a FDR at 5% was performed for Venn diagrams in TM4 and
Cytoscape (http://www.cytoscape.org) was used to design the gene network with genes whose
fold change is 2. The data discussed in this publication have been deposited in NCBI’s Gene
Expression Omnibus [63] and are accessible through GEO Series accession number
GSE113251 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113251).
qPCR
On the same cDNA samples used for microarray experiments, we performed quantitative real-
time PCR (qPCR) analyses of genes and housekeeping genes using SYBR Green PCR master
mix (Applied Bio-systems, Life technologies, UK) on the Stratagene Mx3000P (Agilent
Technologies).
Statistical analysis
Data are expressed as means ± standard error of the mean (SEM). Significant differences
between groups were determined using one-way or two-way analysis of variance (ANOVA)
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followed by Sidak post-hoc testing with Graphpad Prism software (Graphpad Prism 7.0, La
Jolla, CA, USA). A p value <0.05 was considered statistically significant.
Supporting information
S1 Fig. Morphological, anatomical, and histological analysis of hypertrabeculated hearts in
four-chamber views. (A) Long-axis cine images recorded by CMR at end-systole and end-dias-
tole of 3 months-old control (CTL), Nkx2-5ΔTrbE10 (ΔTrbE10) and Nkx2-5ΔTrbE14 (ΔTrbE14)
mutant mice. Arrows indicate excessive trabeculations. RV: right ventricle; IVS: interventricular
septum; LV: left ventricle. (B) Anatomical structure of opened left ventricle of 12 months-old
control, Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutant mice. The dotted lines delimit the free wall
(LV) on the left and the interventricular septum (IVS) on the right. Stars indicate the papillary
muscles. (C) Immunofluorescence with endomucin and RFP or endoglin and SMA antibodies
to delineate the endocardium and capillaries from the arterial vasculature on sagittal sections of
control, Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 adult hearts. On the right panels, high magnifications
of the left ventricular lumen show the numerous endocardial islets in Nkx2-5ΔTrbE10 and Nkx2-
5ΔTrbE14 mutants (arrows). (D) Immunofluorescence with WGA-cy3 to delineate fibrosis on
sagittal sections of control, Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 adult hearts. Scale bar = 1mm.
(TIF)
S2 Fig. Normal morphology of the central conduction system in Nkx2-5 mutants. Immu-
nofluorescence with Contactin-2 (A-F) or Nkx2-5 (A’-F’) and WGA on serial sagittal sections
at the level of the atrioventricular bundle (AVB) or atrioventricular node (AVN) from control
(Ctrl), Nkx2-5ΔTrbE10 (ΔTrbE10) and Nkx2-5ΔTrbE14 (ΔTrbE14) adult hearts. Scale bar = 100μm
(A-F) 50μm (A’-F’).
(TIF)
S3 Fig. Subendocardial fibrosis in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mutants. Trichrome
masson coloration (A) or immunofluorescence with Vimentin and fibronectin antibodies
(B-D) on transversal sections at the mid-ventricular level from control (Ctrl), Nkx2-5ΔTrbE10
and Nkx2-5ΔTrbE14 adult hearts. Scale bar = 100μm.
(TIF)
S4 Fig. Graphs representing the longitudinal follow-up of the EF recorded by MRI in indi-
vidual control, Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mice.
(TIF)
S5 Fig. Quantification of right ventricular function in 3 and 9 month-old mice. Tricuspid
annular plane systolic excursion (TAPSE) measurement by echocardiography shows right ven-
tricular (RV) dysfunction in Nkx2-5ΔTrbE10 and Nkx2-5ΔTrbE14 mice at 9 month-old but not at
3-month-old of age (n = 6–7 per group) , p<0.01 vs control mice.
(TIF)
S6 Fig. Molecular markers associated with hypertrabeculated Nkx2-5 mutant hearts and
mouse models of pathological LVNC. Quantitative real-time PCR performed for a list of
selected genes. The housekeeping gene used was RPL32.
(TIF)
S1 Movie. Short-axis cine videos recorded by MRI of a control mouse. Compilation of three
representative movies from MRI recordings in short axis of the same animal at the time points
(3, 6 and 9 month-old) for a control mouse.
(MP4)
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S2 Movie. Short-axis cine videos recorded by MRI of a Nkx2-5ΔTrbE10 mouse. Compilation
of three representative movies from MRI recordings in short axis of the same animal at the
time points (3, 6 and 9 month-old) for a Nkx2-5ΔTrbE10 mouse.
(MP4)
S3 Movie. Short-axis cine videos recorded by MRI of a Nkx2-5ΔTrbE14 mouse. Compilation
of three representative movies from MRI recordings in short axis of the same animal at the
time points (3, 6 and 9 month-old) for a Nkx2-5ΔTrbE14 mouse.
(MP4)
S4 Movie. Short-axis cine videos recorded by MRI of a fluctuating Nkx2-5ΔTrbE10 mouse.
Compilation of three representative movies from MRI recordings in short axis of the same ani-
mal at the time points (3, 6 and 9 month-old) for a fluctuating Nkx2-5ΔTrbE10 mouse.
(MP4)
S1 File. Excel file with values extracted from the microarrays analysis.
(XLSX)
S2 File. Excel file with values from all quantifications.
(XLSX)
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